You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RP3D

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Trial in Spain, United Kingdom (RP2, nivolumab)

Recruiting
  • Cancer
  • RP2
  • nivolumab
  • Barcelona, Spain
  • +5 more
Nov 11, 2022

Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Duarte (Tazemetostat, Ublituximab, Umbralisib)

Not yet recruiting
  • Recurrent Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Duarte, California
    City of Hope Medical Center
Jul 31, 2022

Acute Myeloid Leukemia Trial in Baltimore (Dose Escalation -tagraxofusp-erzs, Dose Expansion at RP2D -tagraxofusp-erzs)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Dose Escalation -tagraxofusp-erzs
  • Dose Expansion at RP2D -tagraxofusp-erzs
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 27, 2023

Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib, Ublituximab, Umbralisib)

Suspended
  • Mantle Cell Lymphoma
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Pancreas Cancer, Gastric Cancer, Solid Tumor Trial (1 mg/kg IV FL-301, 3 mg/kg IV FL-301, 10 mg/kg IV FL-301)

Withdrawn
  • Pancreas Cancer
  • +2 more
  • 1 mg/kg IV FL-301
  • +5 more
  • (no location specified)
Jan 31, 2022

Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal

Recruiting
  • Cervical Esophagus Adenocarcinoma
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 8, 2022

Rapid Prototyping Models for Patient Education

Completed
  • Patient Education
  • RP model explanation and questionnaire
  • (no location specified)
Jan 27, 2022

Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer

Recruiting
  • Adrenal Gland Pheochromocytoma
  • +3 more
  • Computed Tomography
  • +2 more
  • Bethesda, Maryland
  • +1 more
Jan 3, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 28, 2022

Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)

Not yet recruiting
  • MGMT-Methylated Glioblastoma
  • Recurrent Glioblastoma, IDH-Wildtype
  • (no location specified)
Jun 28, 2022

Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

Active, not recruiting
  • Recurrent Extensive Stage Small Cell Lung Carcinoma
  • Refractory Extensive Stage Small Cell Lung Carcinoma
  • Bakersfield, California
  • +5 more
Jan 5, 2023

Astrocytoma, Glioblastoma, Glioblastoma, IDH-Wildtype Trial in Chicago (drug, other, radiation)

Recruiting
  • Astrocytoma
  • +4 more
  • Mycophenolate Mofetil
  • +3 more
  • Chicago, Illinois
    Northwestern University
Aug 22, 2022

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Not yet recruiting
  • Locally Advanced Leiomyosarcoma
  • +8 more
  • (no location specified)
Jul 6, 2022

Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)

Completed
Has Results
  • Glioblastoma
  • Gliosarcoma
  • 3-Dimensional Conformal Radiation Therapy
  • +10 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 4, 2022

Glioblastoma Trial in Rochester (radiation, procedure, drug, other)

Recruiting
  • Glioblastoma
  • Accelerated Hypofractionated Radiation Therapy
  • +8 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Mar 24, 2023

Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)

Active, not recruiting
  • Malignant Supratentorial Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2021

Multiple Myeloma Trial (CM336_group 1, CM336_group 2a, CM336_group 2b)

Not yet recruiting
  • Multiple Myeloma
  • CM336_group 1
  • +14 more
  • (no location specified)
Mar 18, 2022

Extensive Stage Lung Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Recurrent Lung Small Cell Carcinoma Trial in

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +5 more
  • Indianapolis, Indiana
  • +2 more
Oct 26, 2022

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,

Suspended
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +23 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 23, 2022

Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Rochester (radiation, other, biological, drug, procedure)

Recruiting
  • Glioblastoma
  • +2 more
  • External Beam Radiation Therapy
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Apr 4, 2022

Malignant Glioma Trial in Rochester (procedure, drug, radiation, other)

Active, not recruiting
Has Results
  • Malignant Glioma
  • Diffusion Weighted Imaging
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 15, 2022

Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Rochester (other, biological, drug)

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Nov 3, 2021